Pattern recognition receptors (PRRs) such as TLR9 and NLRP3 are required for the development of inflammation in AP, and their antagonism could provide a new therapeutic strategy for treating AP (13). The gene discussed is NLRP3; the disease is alkaline phosphatase measurement.